[go: up one dir, main page]

IL84261A - Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor - Google Patents

Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor

Info

Publication number
IL84261A
IL84261A IL84261A IL8426187A IL84261A IL 84261 A IL84261 A IL 84261A IL 84261 A IL84261 A IL 84261A IL 8426187 A IL8426187 A IL 8426187A IL 84261 A IL84261 A IL 84261A
Authority
IL
Israel
Prior art keywords
thromboxane
diphenyl
pharmaceutical compositions
synthetase inhibitor
dioxane derivative
Prior art date
Application number
IL84261A
Other languages
English (en)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of IL84261A publication Critical patent/IL84261A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL84261A 1986-11-04 1987-10-23 Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor IL84261A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868626297A GB8626297D0 (en) 1986-11-04 1986-11-04 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL84261A true IL84261A (en) 1991-12-15

Family

ID=10606757

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84261A IL84261A (en) 1986-11-04 1987-10-23 Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor

Country Status (13)

Country Link
US (1) US4908380A (da)
EP (1) EP0266980B1 (da)
JP (1) JPS63130532A (da)
AT (1) ATE81774T1 (da)
AU (1) AU608546B2 (da)
CA (1) CA1308660C (da)
DE (1) DE3782396T2 (da)
DK (1) DK576887A (da)
ES (1) ES2052581T3 (da)
GB (1) GB8626297D0 (da)
GR (1) GR3006099T3 (da)
IL (1) IL84261A (da)
ZA (1) ZA877886B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
CA2637803A1 (en) 2006-01-18 2007-12-06 Evolva Sa Ppar modulators
WO2008089463A2 (en) 2007-01-18 2008-07-24 Evolva Sa Substituted 1,3-dioxanes and their uses
US20120142766A1 (en) * 2007-11-21 2012-06-07 Evolva Sa Substituted 1,3-dioxanes and their uses
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2111050B (en) * 1981-11-19 1985-09-11 Ciba Geigy Ag N-substituted-2-pyridylindoles
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
GB8619450D0 (en) * 1986-08-08 1986-09-17 Glaxo Group Ltd Chemical compositions

Also Published As

Publication number Publication date
GB8626297D0 (en) 1986-12-03
DE3782396T2 (de) 1993-07-08
US4908380A (en) 1990-03-13
DK576887A (da) 1988-05-05
GR3006099T3 (da) 1993-06-21
CA1308660C (en) 1992-10-13
DE3782396D1 (de) 1992-12-03
EP0266980B1 (en) 1992-10-28
AU608546B2 (en) 1991-04-11
JPS63130532A (ja) 1988-06-02
ES2052581T3 (es) 1994-07-16
EP0266980A3 (en) 1989-11-08
ZA877886B (en) 1988-05-04
DK576887D0 (da) 1987-11-03
AU8069887A (en) 1988-05-05
ATE81774T1 (de) 1992-11-15
EP0266980A2 (en) 1988-05-11

Similar Documents

Publication Publication Date Title
IL110031A0 (en) Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them
CS782686A2 (en) Method of benzimidazole derivatives production
ATE65397T1 (de) Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.
NO913684L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
SE8404065D0 (sv) Novel biologically active compounds
SE8505488L (sv) Isosilybinfri silibinin
HUT51298A (en) Process for producing retarde hirudine derivatives and pharmaceutical compositions containing them as active components
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
IL84261A (en) Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor
AU696532B2 (en) Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
NO913683D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
IL85425A (en) Anticonvulsant compositions containing substituted benzoyl anilides, some such novel compounds and process for their preparation
EP0266979A3 (en) Therapeutic agents
NO913685D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
JO1711B1 (en) Therapeutic agents
SE9304065D0 (sv) New compound

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees